FDA begins a probe following the disclosure of Johnson & Johnson (NYSE:JNJ) on Wednesday that one of the active ingredients in a batch of COVID-19 vaccines at its contractor’s premises does not meet quality criteria. Scraps a batch of COVID-19 vaccine According to...
Johnson & Johnson has announced positive results from pre-clinical trial for its lead vaccine candidate that protects against SARS-CoV-2, the virus that causes COVID-19. According to recently published data, the company’s adenovirus serotype 26 (Ad26) vector-based...
